Praxis sinks on late-stage study fail for seizure pill, halts second trial
Praxis Precision Medicines has had a decent run over the past eight months or so, with two major clinical wins. But on Monday, the company disclosed a late-stage failure for its investigational seizure medicine, and ...
June 2, 2026 06:31 AM EDT R&D Praxis sinks on late-stage study fail for seizure pill, halts second trial Elizabeth Cairns Senior biopharma journalist Praxis Precision Medicines has had a decent run over the past eight months or so, with two major clinical wins. But on Monday, the company … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that